← Back to Patent Explorer
US4650769A Expired / Lapsed US ⏱️ 0.0 years remaining

Microcapsules for immune response

Assignee: Fujifilm Holdings Corp
•
Filing: 1984-03-08
•
Granted: 1987-03-17
•
Expires: 2004-03-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Microcapsules for effecting an immune response, especially through agglutination reaction, comprise an antigen or antibody bound to functional groups, such as amino groups, carboxy groups, etc., on a wall surface of the microcapsules via cross linking agents, such as polyfunctional isocyanates, isothiocyanates, etc. The antigen or antibody is strongly bound to the wall surface of the microcapsules to thereby achieve excellent detection sensitivity.

Inventors

  • 👤 Fujio Kakimi
  • 👤 Hiroharu Matsukawa
  • 👤 Yutaka Akiyoshi
  • 👤 Shinzo Kobayashi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 23:54
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; G01N33/54346; B; B01; B01J; B01J13/00; B01J13/02; B01J13/06; B01J13/14; B01J13/16; Y; Y10; Y10S; Y10S436/00; Y10S436/823; Y10S436/829; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 74 words
Microcapsules for effecting an immune response which comprise a wall having an oily substance encapsulated therein as a core and an antigen or antibody bound to a functional group of the wall surface of the microcapsules via a cross linking agent, wherein the average particle size of the microcapsule is in the range of from 0.1 to 30 μm and the microcapsules have a variable specific gravity ranging from about 0.80 to about 1.20.
Claim 2
Dependent Claim 74 words
Microcapsules for effecting an immune response which comprise a wall having an oily substance encapsulated therein as a core and an antigen or antibody bound to a functional group of the wall surface of the microcapsules via a cross linking agent, wherein the average particle size of the microcapsule is in the range of from 0.1 to 30 μm and the microcapsules have a variable specific gravity ranging from about 0.80 to about 1.20.
Claim 3
Dependent Claim 29 words
The microcapsules of claim 1 wherein said functional group is selected from the group consisting of an amino group, a carboxy group, a hydroxy group and a mercapto group.
Claim 4
Dependent Claim 54 words
The microcapsules of claim 1 wherein said wall is prepared by reacting a compound selected from the group consisting of a polyfunctional isocyanate, a polyfunctional isothiocyanate, a polyfunctional acid chloride and a polyfunctional epoxy compound with an aminocontaining substance selected from the group consisting of ethylenediamine, hexamethylene diamine, cyclic amines, arginine, lysine and cystine.
Claim 5
Dependent Claim 55 words
The microcapsules of claim 1 wherein said wall is prepared by reacting a compound selected from the group consisting of a polyfunctional isocyanate, a polyfunctional isothiocyanate, a polyfunctional acid chloride and a polyfunctional epoxy compound with a carboxy-containing substance selected from the group consisting of carboxymethyl cellulose, polyacrylic acid, polymethacrylic acid and polystyrene carboxylic acid.
Claim 6
Dependent Claim 48 words
The microcapsules of claim 1 wherein said wall is prepared by reacting a compound selected from the group consisting of a polyfunctional isocyanate, a polyfunctional isothiocyanate, a polyfunctional acid chloride and a polyfunctional epoxy compound with thiourea to form microcapsule walls and then reducing the thus formed microcapsules.
Claim 7
Dependent Claim 67 words
The microcapsules of claim 1 wherein said wall is prepared by reacting a compound selected from the group consisting of a polyfunctional isocyanate, a polyfunctional isothiocyanate, a polyfunctional acid chloride and a polyfunctional epoxy compound with an ester compound selected from the group consisting of a polyacrylate and a polymethacrylate to form the microccapsule wall, and then the microcapsule wall thus formed is hydrolyzed under acidic conditions.
Claim 8
Dependent Claim 25 words
The microcapsules of claim 3, 4, 5 or 6 wherein said polyfunctional isothiocyanate is selected from the group consisting of phenylene diisothiocyanate and ethylene diisothiocyanate.
Claim 9
Dependent Claim 29 words
The microcapsules of claim 3, 4, 5 or 6 wherein said polyfunctional isocyanate is selected from the group consisting of toluene diisocyanate, xylene diisocyanate, tolylene diisocyanate and hexamethylene diisocyanate.
Claim 10
Dependent Claim 17 words
The microcapsules of claim 3, 4, 5 or 6 wherein said polyfunctional acid chloride is 1-hydroxy-2,4-disulfonyl chloride.
Claim 11
Dependent Claim 16 words
The microcapsules of claim 3, 4, 5 or 6 wherein said polyfunctional epoxy compound is diepoxybenzene.
Claim 12
Dependent Claim 45 words
The microcapsules of claim 1 wherein said cross linking agent is employed in an amount of 5 to 25 wt% and a compound introducing said functional group into the microcapsule in a range of 2 to 20 wt%, based upon a core of the microcapsule.
Claim 13
Dependent Claim 30 words
The microcapsules of claim 1 wherein said functional group is present in a concentration of at least 10 -9 mol. per 1 mg. of the solids content of the microcapsules.
Claim 14
Dependent Claim 31 words
The microcapsules of claim 12 wherein said functional group is present in a concentration of from 10 -9 to 10 -5 ml. per 1 mg. of solids content of the microcapsules.
Claim 15
Dependent Claim 47 words
The microcapsules of claim 1 wherein the cross linking agent is a compound selected from the group consisting of a dialdehyde, a diisocyanate, an amide ester, a disulfonyl chloride, a halonitrobenzene, a water-soluble carbodiamide, an isoxazolium salt, an alkyl chloroformate, a N,N'-o-phenylenedimaleimide ester or an m-maleimidobenzoyl-N-hydroxysuccinimide ester.
Claim 16
Dependent Claim 37 words
The microcapsules of claim 1 wherein the cross linking agent is a compound selected from the group consisting of glutaraldehyde, toluene-2,4-diisocyanate, p-phenylenedithioisocyanate, diethyl maloneimidate, 1-hydroxy-2,4-disulfonyl chloride, p,p'-difluoro-m,m'-dinitrophenylsulfonic acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 1-cyclohexyl-3-(2-morpholinyl-4-ethyl)carbodiimidomethyl-p-toluenesulfonic acid, N-ethyl-5-phenylisoxazolium-3'-sulfonic acid, and ethyl chloroformate.
Claim 17
Dependent Claim 16 words
The microcapsules of claim 1, having an average particle size of from 0.5 to 10 μm.

References Cited (Backward Citations)

US3857931A Cited
US4021364A Cited
US4193983A Cited
US4255411A Cited
US4342739A Cited
US4254096A Cited
US4349530A Cited
US4362697A Cited
US4559303A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-16 1990-09-15 1991-03-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-16 1994-09-15 1995-03-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-16 1998-09-15 1999-03-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag